Zobrazeno 1 - 10
of 100
pro vyhledávání: '"J, Trapani A"'
Autor:
Andrew S, Bomback, David, Kavanagh, Marina, Vivarelli, Matthias, Meier, Yaqin, Wang, Nicholas J A, Webb, Angelo J, Trapani, Richard J H, Smith
Publikováno v:
Kidney International Reports. 7:2150-2159
Complement 3 glomerulopathy (C3G) is a rare kidney disease characterized by dysregulation of the alternative pathway (AP) of the complement system. About 50% of patients with C3G progress to kidney failure within 10 years of diagnosis. Currently, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9459cb8f6043be21a7930696affaa654
https://doi.org/10.1016/j.ekir.2022.07.004
https://doi.org/10.1016/j.ekir.2022.07.004
Autor:
C.M. Nester, U. Eisenberger, A. Karras, M. le Quintrec-Donnette, L. Lightstone, M. Praga, G. Remuzzi, M. Jose Soler, J. Liu, M. Meier, R. Tawfik, G. Junge, A. Biondani, A. J Trapani, N. Webb, E. K Wong
Publikováno v:
Kidney International Reports. 8:S270-S271
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0d293a436f7be558fa0941aca08d4a7
https://doi.org/10.1016/j.ekir.2023.02.610
https://doi.org/10.1016/j.ekir.2023.02.610
Autor:
Erica Daina, Yaqin Wang, Matthias Meier, Nicholas Webb, Manuel Praga, Moglie Le Quintrec, Junhao Liu, Edwin Kwan Soon Wong, Angelo J. Trapani, Guido Junge, Carla M. Nester, Giuseppe Remuzzi
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Iptacopan (LNP023) is a highly selective oral low molecular weight inhibitor of Factor B, a key complement alternative pathway protease. We have previously reported data from an interim analysis (IA) of a Phase 2 study in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a731afa1946ab619dd5ec82e85f0437
https://doi.org/10.1093/ndt/gfab121.005
https://doi.org/10.1093/ndt/gfab121.005
Autor:
Patrick Breheny, Monica Hall, Alan Charney, Martin Lefkowitz, Angelo J. Trapani, Richard J.H. Smith, Carla M. Nester, Yaqin Wang
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Considerable knowledge gaps exist in our understanding of the natural history of C3 glomerulopathy (C3G). Disease rarity, multiple nomenclature changes, and the inclusion of dissimilar cases in historical cohorts have precluded re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d95c428f1ea58d3bee0a18036755284b
https://doi.org/10.1093/ndt/gfab092.0014
https://doi.org/10.1093/ndt/gfab092.0014
Autor:
N, Giannetta, S, Dionisi, A, Stievano, S, Eltaybani, M E, Abdelgawad, M R, Katigri, T T, Azadboni, P J, López-Soto, I, Morales-Cané, I, Ali, J, Urban, S, Shrestha, M, Christensen, A, Voutilainen, A, Vaajoki, K, Hamdan, G, Rubicini, J Y, Rivera Pizarro, G, Liquori, M, Cassar, J, Trapani, G, Rocco, G B, Orsi, E, Di Simone, M, Di Muzio
The aim of the study was to explore the degree of agreement of intensive care unit nurses working on a set of medication error preventive strategies and to examine possible predictors of nurses' knowledge, attitude and behavior.Observational, interna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3a198d815c0b74210f46352d4a4b899e
http://hdl.handle.net/11573/1597590
http://hdl.handle.net/11573/1597590
Autor:
Nester, C.M., Eisenberger, U., Karras, A., le Quintrec-Donnette, M., Lightstone, L., Praga, M., Remuzzi, G., Jose Soler, M., Liu, J., Meier, M., Tawfik, R., Junge, G., Biondani, A., J Trapani, A., Webb, N., K Wong, E.
Publikováno v:
In Kidney International Reports March 2023 8(3) Supplement:S270-S271
Autor:
Christopher Bush, Marco Metra, Kirkwood F. Adams, Beth A. Davison, Peter S. Pang, Adriaan A. Voors, G. Michael Felker, Gerasimos Filippatos, Angelo J. Trapani, Karl Werdan, Rajnish Saini, Sam L. Teichman, Maria Dorobantu, Elaine Unemori, Liliana Grinfeld, Thomas Severin, Christoph Schumacher, Piotr Ponikowski, Gad Cotter, Josep Masip, Barry H. Greenberg, Guillaume Jondeau, John R. Teerlink, Alon Marmor
Publikováno v:
LANCET, 381(9860), 29-39. ELSEVIER SCIENCE INC
Summary Background Serelaxin, recombinant human relaxin-2, is a vasoactive peptide hormone with many biological and haemodynamic effects. In a pilot study, serelaxin was safe and well tolerated with positive clinical outcome signals in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab202c1fb14bd277e679d2bae8839061
https://research.rug.nl/en/publications/496e6092-228e-403f-8353-96ba44b0acdb
https://research.rug.nl/en/publications/496e6092-228e-403f-8353-96ba44b0acdb
Autor:
Angelo J. Trapani, Christopher Bush, Marco Metra, Maria Dorobantu, Kirkwood F. Adams, Liliana Grinfeld, Barry H. Greenberg, Gad Cotter, Relax-Ahf Investigators, Peter S. Pang, Sam L. Teichman, Christopher L. Edwards, Elaine Unemori, Guillaume Jondeau, Christoph Schumacher, Josep Masip, Gerasimos Filippatos, Adriaan A. Voors, G. Michael Felker, John R. Teerlink, Rajnish Saini, Karl Werdan, Piotr Ponikowski, Thomas Severin, Alon Marmor, Beth A. Davison, Margaret F. Prescott
Publikováno v:
Journal of the American College of Cardiology. 61:196-206
Objectives The aim of this study was to assess the effects of serelaxin on short-term changes in markers of organ damage and congestion and relate them to 180-day mortality in patients with acute heart failure. Background Hospitalization for acute he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dd014dd7571f904bf3eae605365d3d6
https://doi.org/10.1016/j.jacc.2012.11.005
https://doi.org/10.1016/j.jacc.2012.11.005
Autor:
Thomas Peppard, Daniel Hartman, Karl Andersen, Peter James Van Ess, Martin Lefkowitz, Angelo J. Trapani, David Hermann
Publikováno v:
The Journal of Clinical Hypertension. 14:580-587
Blockade of the renin-angiotensin-aldosterone system (RAAS) is an established method to lower blood pressure in patients with hypertension. Aldosterone, the end product of the RAAS cascade, acts by increasing salt reabsorption in the kidney and catec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94aa3421a977aacde29d317eef07e2e3
https://doi.org/10.1111/j.1751-7176.2012.00667.x
https://doi.org/10.1111/j.1751-7176.2012.00667.x
Publikováno v:
Tissue Antigens. 3:470-476
Beginning in 1969, HL–A antigens were determined for 85 Caucasian patients with acute lymphocytic leukemia (ALL). HL–A2 was the only antigen significantly different from a normal racial control group. It was present in 65 % of patients as compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf9ae2a3029433fe1f8dd57e47bfad1f
https://doi.org/10.1111/j.1399-0039.1973.tb00517.x
https://doi.org/10.1111/j.1399-0039.1973.tb00517.x